BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Lymphoma

1. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. 5-Sep
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. 9-Sep
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]